Myocardial and plasma renin-angiotensinogen dynamics during pressure- induced cardiac hypertrophy

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 274, Issue 3 43-3, 1998, Pages

  Heller, Lois J ^b   Opsahl, John A ^b   Wernsing, Shane E ^b   Saxena, Retu ^b   Katz, Stephen A ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

Aortic constriction; Cardiac myocytes; Hypertension; Myocardium; Renin angiotensin system

Indexed keywords

ANGIOTENSIN I; ANGIOTENSINOGEN; RENIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CONTROLLED STUDY; FEMALE; HEART HYPERTROPHY; HEART LEFT VENTRICLE; HEART MUSCLE CELL; NONHUMAN; PLASMA; PRIORITY JOURNAL; RAT;

EID: 0031943608     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1998.274.3.r849     Document Type: Article

References (33)

1. Baker, K. M., M. I. Chernin, S. K. Wixson, and J. F. Aceto. Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am. J. Physiol. 259 (Heart Circ. Physiol. 28): H324-H332, 1990.
2. Boer, P. H., M. Ruzicka, W. Lear, E. Harmsen, J. Rosenthal, and F. H. H. Leenen. Stretch-mediated activation of cardiac renin gene. Am. J. Physiol. 267 (Heart Circ. Physiol. 36): H1630-H1636, 1994.
3. Brilla, C. G., G. P. Reams, B. Maisch, and K. T. Weber. Renin-angiotensin system and myocardial fibrosis in hypertension: regulation of the myocardial collagen matrix. Eur. Heart J. 14: 57-61, 1993.
4. Bruckschlegel, G., S. R. Holmer, K. Jandeleit, D. Grimm, F. Muders, E. P. Kromer, G. A. J. Riegger, and H. Schunkert. Blockade of the renin-angiotensin system in cardiac pressure-overload hypertrophy in rats. Hypertension 25: 250-259, 1995.
5. Dahlof, B. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review. J. Hum. Hypertens. 9: S37-S44, 1995.
6. Danser, A. H. J., J. P. van Kats, P. J. J. Admiraal, F. H. M. Derkz, J. M. J. Lamers, P. D. Verdouw, P. R. Saxena, and M. A. D. H. Schalekamp. Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis. Hypertension 24: 37-48, 1994.
7. Dzau, V. J. Tissue renin-angiotensin system in myocardial hypertrophy and failure. Arch. Intern. Med. 153: 937-942, 1993.
8. 1 expression. Hypertension 23: 587-592, 1994.
9. Figueiredo, A. F. S., Y. Takii, H. Tsuji, K. Kato, and T. Inagami. Rat kidney renin and cathespin D: purification and comparison of properties. Biochem. J. 22: 5467-5481, 1983.
10. Johnston, C. I. Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling. Hypertension 23: 258-268, 1994.
11. Katz, S.A., P. A. Abraham, and J.A. Opsahl. Measurement of human active renin heterogeneity. Renal Physiol. Biochem. 15: 240-248, 1992.
12. Katz, S.A., J. A. Opsahl, P. A. Abraham, and M. J. Gardner. The relationship between renin isoelectric forms and renin glycoforms. Am. J. Physiol. 267 (Regulatory Integrative Comp. Physiol. 36): R244-R252, 1994.
13. Katz, S. A., J. A. Opsahl, M. M. Lunzer, L. M. Forbis, and A. T. Hirsch. Effect of bilateral nephrectomy on active renin, angiotensinogen, and renin glycoforms in plasma and myocardium. Hypertension 30: 259-266, 1997.
14. Kawaguchi, H., and A. Kitabatake. Renin-angiotensin system in the failing heart. J. Mol. Cell. Cardiol. 27: 201-209, 1995.
15. Lindpaintner, K., and D. Ganten. The cardiac renin-angiotensin system. Circ. Res. 68: 905-921, 1991.
16. Lindpaintner, K., M. Jin, N. Niedermaier, M. J. Wilhelm, and D. Ganten. Cardiac angiotensinogen and its local activation in the isolated perfused beating heart. Circ. Res. 67: 564-573, 1990.
17. Linz, W., J. Schaper, G. Wiemer, U. Albus, and B. A. Scholkens. Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: a one year study in rats. Br. J. Pharmacol. 107: 970-975, 1992.
18. Linz, W., B. A. Scholkens, and D. Ganten. Converting enyzme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. Clin. Exp. Hypertens. A11: 1325-1350, 1989.
19. Lipke, D. W., K. J. McCarthy, T. S. Elton, S. S. Arcot, S. Oparil, and J. R. Couchman. Coarctation induces alterations in basement membranes in the cardiovascular system. Hypertension 22: 743-753, 1993.
20. Michelini, L. C., M. de Oliveira, and M. dos Santos. Baroreceptor reflex control of heart rate during development of coarctation hypertension. Hypertension 19: II-159-II-163, 1992.
21. Mohabir, R., S. D. Young, and A. M. Strosberg. Role of angiotensin in pressure overload-induced hypertrophy in rats: effects of angiotensin-converting enzyme inhibitors, and AT1 receptor antagonist and surgical reversal. J. Cardiovasc. Pharmacol. 23: 291-299, 1994.
22. Nagasawa, K., R. Zimmerman, B. Munkel, W. Linz, B. A. Scholkens, and J. Schaper. Extracellular matrix deposition in hypertensive hearts; antifibrotic effects of ramipril. Eur. Heart J. 16: 33-37, 1995.
23. Opsahl, J. A., P. A. Abraham, and S. A. Katz. Effect of acute stimulation of renin secretion on renal renin content in vivo. Kidney Int. 38: 440-446, 1990.
24. Opsahl, J. A., M. R. Goldberg, and S. A. Katz. Effect of acute and chronic losartan therapy on active and inactive renin and active renin glycoforms. Am. J. Hypertens. 8: 1090-1098, 1995.
25. Plank, B., G. Raberger, G. Brugger, and L. Adler-Kastner. The determination of the myocardial extracellular space in the cat in vivo: a comparative methodological study. Basic Res. Cardiol. 71: 173-178, 1976.
26. Polimeni, P. I., A. F. Cutilletta, and M. D. Otten. Cation distributions in the hypertrophic myocardium (aortic constriction) of the rat. Cardiovasc. Res. 17: 170-176, 1983.
27. Raman, V. K., Y. A. Lee, and K. Lindpaintner. The cardiac renin-angiotensin-aldosterone system and hypertensive cardiac hypertrophy. Am. J. Cardiol. 76: 18D-23D, 1995.
28. Regan, C. P., P. G. Anderson, S. P. Bishop, and K. H. Berecek. Captopril prevents vascular and fibrotic changes but not cardiac hypertrophy in aortic-banded rats. Am. J. Physiol. 271 (Heart Circ. Physiol. 40): H906-H913, 1996.
29. Reil, G. H., R. Frombach, R. Kownatzki, W. Quante, and P. R. Licthlen. Ascorbic acid: a nonradioactive extracellular space marker in canine heart. Am. J. Physiol. 253 (Heart Circ. Physiol. 22): H1305-H1314, 1987.
30. Rhaleb, N. E., X. P. Yang, A. G. Scicli, and O. A. Carretero. Role of kinins and nitric oxide in the antihypertrophic effect of ramipril. Hypertension 23: 865-868, 1994.
31. Solem, L. E., L. J. Heller, and K. B. Wallace. Dose-dependent increase in sensitivity to calcium-induced mitochondrial dysfunction and cardiomyocyte cell injury by Doxorubicin. J. Mol. Cell. Cardiol. 28: 1023-1032, 1996.
32. Von Lutterotti, N., D. F. Catanzaro, J. E. Sealey, and J. H. Laragh. Renin is not synthesized by cardiac and extrarenal vascular tissues. Circulation 89: 458-470, 1994.
33. Weber, K. T., Y. Sun, and E. Guarda. Structural remodeling in hypertensive heart disease and the role of hormones. Hypertension 23: 869-877, 1994.